Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

SeD's LOI with AMBS is dead

its now going on 2 years trying to resuscitate AMBS - with no takers anywhere in sight

problem is / was / always will be is that AMBS's "business model" was flawed from the start

buying used niche biotech products cheap to take to the next level requires deep pockets, partners, collateralization, VC's, SEDA's, coupled with multiple years involving seasoned experience professionals vs that of a bush league x-college football player

AMBS ran aground financially advancing their suite of products through developmental hurdles that were too costly, too time consuming and ultimately into test trials that simply became unsustainable

equity distribution only lasts so long when you have no ROI for shareholders

Gerald lying about MJFF MANF Grant funding approval was the 1st in a series of habitual lies that caused an irreversible crack in the proverbial foundation wall of AMBS

http://www.amarantus.com/news/press-releases/detail/313/correction-amarantus-biosciences-updates-shareholders-on

boy CEO Gerald was "star-stuck" and was completely void of the realities of all inherent biopharma start-up costs, hurdles and time-to-market principles

Shelly Kraft of SNN Live became intuitively aware of this as well, when it became too little too late - as did Jason Napodano of Seeking Alpha